Categories
Business News

Next-generation Sequencing (NGS) Market by Product (NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE), Consumables, Bioinformatics, Services (EXOME, RNA, DENOVO), Technology- Global Forecast to 2025

The report titled “Next-Generation Sequencing (NGS) Market” sheds a concentrated focus on the Next-Generation Sequencing (NGS) industry in terms of market driver, opportunities, restraints of global segmentation. Further data on the reports also includes demographic conditions, over-turning changing business cycles and analyzing country-to-market.

Browse 109 Market Data Tables and 44 Figures spread through 228 Pages and in-depth TOC on “Next-Generation Sequencing (NGS) Market Research Report” https://www.reportsnreports.com/contacts/requestsample.aspx?name=508000

#Key Players- Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg).

The Next-Generation Sequencing Market, by technology, is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other sequencing technologies. The sequencing by synthesis segment is expected to command the largest share of the next-generation sequencing market in 2018.

On the Basis of End User, the next-generation sequencing market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The hospitals & clinics segment is estimated to witness the highest growth rate during the forecast period.

The Next-Generation Sequencing Market in the Asia Pacific is expected to witness the highest CAGR from 2018 to 2024. Factors such as increasing financial support from public as well as private agencies for NGS based research and diagnostics, increasing number of NGS-based research projects, increasing awareness about precision medicine, and high incidence of chronic diseases in the region are driving the growth of the next-generation sequencing market in the APAC region.

Breakdown of supply-side primary interviews: by company type, designation, and region:

  • By Company Type: Tier 1 – 40%, Tier 2 – 25%, and Tier 3 – 36%
  • By Designation: C-level – 43%, Director-level – 22%, and Others – 35%
  • By Region: North America – 37%, Europe – 12%, APAC – 41%, and RoW -10%

This Report studies the next-generation sequencing market based on product & service, technology, application, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.

Inquire for DISCOUNT @ https://www.reportsnreports.com/contacts/discount.aspx?name=508000